Blog

16 04, 2026

How to Evaluate Stability When the Biotech Market Is Anything but Stable

By |2026-04-01T05:44:21-04:00April 16th, 2026|

If you’ve been in biotech for any length of time, you already understand one thing. Stability is never guaranteed. A company can look strong from the outside. Good funding, promising science, a pipeline that makes sense, and a hiring push that suggests momentum. Everything lines up on paper. Then [...]

2 04, 2026

What Volatile Markets Reveal About the Technology Leaders Who Thrive

By |2026-04-01T05:23:45-04:00April 2nd, 2026|

If you’ve been doing this long enough, you’ve seen both sides of it. You’ve seen when everything’s growing and it almost feels like you can’t mess it up. Budgets are there, hiring’s happening, projects are getting approved. You make a few mistakes, it doesn’t really hurt you. The market [...]

19 03, 2026

Why Biotech Companies Break Their Technology Stack Before They Scale It

By |2026-03-19T10:40:23-04:00March 19th, 2026|

Biotech companies don’t wake up one day and decide to build a messy technology environment. It happens gradually. A managed service provider gets hired to run day-to-day operations. A consultant comes in to implement a new platform. Another vendor gets brought in for security. Cloud usage expands because growth [...]

5 03, 2026

A Common Technology Leadership Hire Biotech Companies Make at the Wrong Stage

By |2026-03-05T10:08:37-05:00March 5th, 2026|

There is a hiring pattern I see in biotech that creates friction, even when the person hired is experienced and capable. On paper, the hire makes complete sense. The person has held the title before. They have worked in impressive organizations. They have led teams. They understand systems. There’s [...]

5 02, 2026

Knowing When It’s Time for Technical People to Grow Into a Non-Technical Role

By |2026-02-05T10:51:30-05:00February 5th, 2026|

I have watched this happen to technical people more times than I can count. It usually does not announce itself. Someone who is capable and respected keeps doing what they have always done. They learn the next tool. They master the next platform. They go deeper, because going deep [...]

2 01, 2026

2026 Biotech Recruitment Outlook: Preparing for a Competitive Talent Market

By |2026-01-02T13:49:52-05:00January 2nd, 2026|

Over the past year, most biotech leaders I speak with have been asking variations of the same question. Not “Is the market good or bad?” but “How do we plan when things still feel uncertain?” That uncertainty hasn’t disappeared, but it has changed. Conversations are less about survival and [...]

4 12, 2025

The CIO Shift: Lessons from SIM Boston’s Roundtable

By |2025-12-04T09:39:37-05:00December 4th, 2025|

On November 4th, I had the opportunity to speak at SIM Boston’s Life Sciences Roundtable, hosted at Dyne Therapeutics. The session focused on “The Evolving Role of the Life Sciences CIO,” and brought together about 35 to 40 biotech and pharma technology leaders, CIOs, VPs, and IT strategists, all [...]

Go to Top